• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间质性肺疾病与糖尿病。

Interstitial lung disease and diabetes.

作者信息

Rajasurya Venkat, Gunasekaran Kulothungan, Surani Salim

机构信息

Department of Pulmonary and Critical Care, Novant Health System, Winston-Salem, NC 27103, United States.

Department of Pulmonary and Critical Care, Yale-New Haven Health Bridgeport Hospital, CT 06610, United States.

出版信息

World J Diabetes. 2020 Aug 15;11(8):351-357. doi: 10.4239/wjd.v11.i8.351.

DOI:10.4239/wjd.v11.i8.351
PMID:32864047
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7438183/
Abstract

Diabetes mellitus (DM) is a chronic metabolic disease and its prevalence has been steadily increasing all over the world. DM and its associated micro and macrovascular complications result in significant morbidity and mortality. The microvascular complications are usually manifested as retinopathy, neuropathy, nephropathy and macrovascular complications generally affect the cardiovascular system. In addition to these complications, DM also affects the lungs because of its rich vascularity and abundance in connective tissue (collagen and elastin). DM has been found to cause microvascular complications and proliferation of extracellular connective tissue in the lungs, leading to decline in lung function in a restrictive pattern. Interstitial lung disease (ILD) includes a diverse group of disease conditions characterized by different degrees of inflammation and fibrosis in the pulmonary parenchyma. Idiopathic pulmonary fibrosis (IPF) is one of the common type of idiopathic interstitial pneumonia with a high mortality rate. IPF is characterized by chronic progressive fibrosis leading to progressive respiratory failure. In this review we focus on lung as the target organ in DM and the association of DM and ILD with special emphasis on IPF.

摘要

糖尿病(DM)是一种慢性代谢性疾病,其在全球的患病率一直在稳步上升。糖尿病及其相关的微血管和大血管并发症会导致显著的发病率和死亡率。微血管并发症通常表现为视网膜病变、神经病变、肾病,而大血管并发症一般会影响心血管系统。除了这些并发症外,由于肺血管丰富且结缔组织(胶原蛋白和弹性蛋白)含量高,糖尿病也会影响肺部。已发现糖尿病会导致肺部微血管并发症和细胞外结缔组织增生,从而导致肺功能呈限制性模式下降。间质性肺疾病(ILD)包括多种疾病状态,其特征是肺实质存在不同程度的炎症和纤维化。特发性肺纤维化(IPF)是特发性间质性肺炎的常见类型之一死亡率很高。IPF的特征是慢性进行性纤维化,导致进行性呼吸衰竭。在本综述中,我们重点关注糖尿病中的肺作为靶器官以及糖尿病与间质性肺疾病的关联,特别强调特发性肺纤维化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1adf/7438183/5705a9666d91/WJD-11-351-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1adf/7438183/5705a9666d91/WJD-11-351-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1adf/7438183/5705a9666d91/WJD-11-351-g001.jpg

相似文献

1
Interstitial lung disease and diabetes.间质性肺疾病与糖尿病。
World J Diabetes. 2020 Aug 15;11(8):351-357. doi: 10.4239/wjd.v11.i8.351.
2
Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?综述系列:间质性肺病的各个方面:结缔组织病相关间质性肺病:它与特发性肺纤维化有何不同?临床方法应如何有所不同?
Chron Respir Dis. 2011;8(1):53-82. doi: 10.1177/1479972310393758.
3
The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.伴有抗氨酰tRNA合成酶抗体的间质性肺疾病的长期预后。
Respir Med. 2017 Jun;127:57-64. doi: 10.1016/j.rmed.2017.04.007. Epub 2017 Apr 15.
4
Survival and outcomes after lung transplantation for connective tissue disease-associated interstitial lung diseases.结缔组织病相关间质性肺疾病肺移植后的生存率和结局。
Clin Rheumatol. 2021 Sep;40(9):3789-3795. doi: 10.1007/s10067-021-05704-9. Epub 2021 Mar 23.
5
Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management.特发性肺纤维化的合并症:识别与管理
Front Med (Lausanne). 2017 Aug 2;4:123. doi: 10.3389/fmed.2017.00123. eCollection 2017.
6
Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.特发性肺纤维化以外的间质性肺疾病患者急性加重后的预后。
Clin Respir J. 2021 Mar;15(3):336-344. doi: 10.1111/crj.13304. Epub 2020 Dec 10.
7
Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.结缔组织病相关性间质性肺炎与慢性纤维化特发性间质性肺炎的临床过程和死亡率比较。
Kaohsiung J Med Sci. 2019 Jun;35(6):365-372. doi: 10.1002/kjm2.12066. Epub 2019 Mar 26.
8
Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.与自身抗体相关的特发性间质性肺炎:一项为期1年的大型病例系列研究
Chest. 2017 Jul;152(1):103-112. doi: 10.1016/j.chest.2017.03.004. Epub 2017 Mar 12.
9
Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA.基于美国保险索赔数据的非特发性肺纤维化进行性纤维化性间质性肺疾病患者的医疗资源利用和费用。
Adv Ther. 2020 Jul;37(7):3292-3298. doi: 10.1007/s12325-020-01380-4. Epub 2020 May 21.
10
Mechanical ventilation for acute respiratory failure due to idiopathic pulmonary fibrosis versus connective tissue disease-associated interstitial lung disease: Effectiveness and risk factors for death.特发性肺纤维化和结缔组织病相关性间质性肺疾病所致急性呼吸衰竭的机械通气:有效性和死亡的危险因素。
Clin Respir J. 2020 Oct;14(10):918-932. doi: 10.1111/crj.13223. Epub 2020 Jun 9.

引用本文的文献

1
From Glucotoxicity to Lung Injury: Emerging Perspectives on Diabetes-Associated Respiratory Complications.从糖毒性到肺损伤:糖尿病相关呼吸并发症的新观点
Lung. 2025 Jul 15;203(1):80. doi: 10.1007/s00408-025-00834-2.
2
Blood Glucose Levels, Inflammation, and Mortality in Asthmatic Populations: A Prospective Cohort Study.哮喘人群中的血糖水平、炎症与死亡率:一项前瞻性队列研究
J Epidemiol Glob Health. 2025 Jun 2;15(1):80. doi: 10.1007/s44197-025-00425-7.
3
Evaluating the impact of type 2 diabetes mellitus on pulmonary vascular function and the development of pulmonary fibrosis.

本文引用的文献

1
Diabetic lung disease: fact or fiction?糖尿病肺部疾病:事实还是虚构?
Rev Endocr Metab Disord. 2019 Sep;20(3):303-319. doi: 10.1007/s11154-019-09516-w.
2
Sitagliptin-induced diffuse alveolar hemorrhage mimicking pulmonary edema.西他列汀诱发酷似肺水肿的弥漫性肺泡出血。
J Family Med Prim Care. 2018 Mar-Apr;7(2):480-481. doi: 10.4103/jfmpc.jfmpc_160_17.
3
Metformin reverses established lung fibrosis in a bleomycin model.二甲双胍可逆转博莱霉素模型中已建立的肺纤维化。
评估 2 型糖尿病对肺血管功能和肺纤维化发展的影响。
Front Endocrinol (Lausanne). 2024 Jul 10;15:1431405. doi: 10.3389/fendo.2024.1431405. eCollection 2024.
4
Effect of anti-diabetic agent on interstitial lung disease in patients with diabetes mellitus.抗糖尿病药物对糖尿病患者间质性肺病的影响。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):581-589. doi: 10.1007/s00210-024-03296-0. Epub 2024 Jul 20.
5
Multi-omics analysis of diabetic pig lungs reveals molecular derangements underlying pulmonary complications of diabetes mellitus.多组学分析糖尿病猪肺,揭示糖尿病肺部并发症的分子失调。
Dis Model Mech. 2024 Jul 1;17(7). doi: 10.1242/dmm.050650. Epub 2024 Jul 23.
6
Glycolysis and beyond in glucose metabolism: exploring pulmonary fibrosis at the metabolic crossroads.糖酵解及其以外的葡萄糖代谢:在代谢十字路口探索肺纤维化。
Front Endocrinol (Lausanne). 2024 May 24;15:1379521. doi: 10.3389/fendo.2024.1379521. eCollection 2024.
7
Chlorogenic Acid Inhibits Progressive Pulmonary Fibrosis in a Diabetic Rat Model.绿原酸抑制糖尿病大鼠肺纤维化的进展。
Iran J Med Sci. 2024 Feb 1;49(2):110-120. doi: 10.30476/IJMS.2023.96535.2868. eCollection 2024 Feb.
8
The Impact of Chronic Comorbidities on Outcomes in Acute Exacerbations of Idiopathic Pulmonary Fibrosis.慢性合并症对特发性肺纤维化急性加重期预后的影响
Life (Basel). 2024 Jan 21;14(1):156. doi: 10.3390/life14010156.
9
Editorial: Cellular and molecular mechanisms of lung regeneration, repair, and fibrosis.社论:肺再生、修复和纤维化的细胞与分子机制
Front Cell Dev Biol. 2024 Jan 8;11:1346875. doi: 10.3389/fcell.2023.1346875. eCollection 2023.
10
Pulmonary disease in diabetes.糖尿病中的肺部疾病
J Diabetes. 2023 Dec;15(12):1008-1010. doi: 10.1111/1753-0407.13509.
Nat Med. 2018 Aug;24(8):1121-1127. doi: 10.1038/s41591-018-0087-6. Epub 2018 Jul 2.
4
Breathlessness and Restrictive Lung Disease: An Important Diabetes-Related Feature in Patients with Type 2 Diabetes.呼吸困难和限制性肺病:2 型糖尿病患者的一个重要糖尿病相关特征。
Respiration. 2018;96(1):29-40. doi: 10.1159/000488909. Epub 2018 Jun 6.
5
Lifestyle Behaviors and Clinical Outcomes in Idiopathic Pulmonary Fibrosis.特发性肺纤维化的生活方式行为与临床结局。
Respiration. 2018;95(1):27-34. doi: 10.1159/000481202. Epub 2017 Oct 19.
6
A Protective Role of Glibenclamide in Inflammation-Associated Injury.格列本脲在炎症相关损伤中的保护作用。
Mediators Inflamm. 2017;2017:3578702. doi: 10.1155/2017/3578702. Epub 2017 Jun 27.
7
Liraglutide prevents and reverses monocrotaline-induced pulmonary arterial hypertension by suppressing ET-1 and enhancing eNOS/sGC/PKG pathways.利拉鲁肽通过抑制 ET-1 并增强 eNOS/sGC/PKG 通路来预防和逆转野百合碱诱导的肺动脉高压。
Sci Rep. 2016 Sep 1;6:31788. doi: 10.1038/srep31788.
8
Metformin attenuates lung fibrosis development via NOX4 suppression.二甲双胍通过抑制NOX4减轻肺纤维化的发展。
Respir Res. 2016 Aug 30;17(1):107. doi: 10.1186/s12931-016-0420-x.
9
Vildagliptin-induced acute lung injury: a case report.维格列汀诱发的急性肺损伤:一例报告
J Med Case Rep. 2016 Aug 12;10(1):225. doi: 10.1186/s13256-016-1006-4.
10
Pioglitazone-induced Pulmonary Injury in a Very Elderly Patient.
Intern Med. 2016;55(13):1779-82. doi: 10.2169/internalmedicine.55.6330. Epub 2016 Jul 1.